These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 14994404

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation.
    Jackson SL, Peterson GM, Vial JH.
    Ann Pharmacother; 2004 Nov; 38(11):1794-9. PubMed ID: 15454583
    [Abstract] [Full Text] [Related]

  • 3. Physician's awareness of the prevention of corticosteroid induced osteoporosis.
    Ungprasert S, Wangkaew S, Louthrenoo W.
    J Med Assoc Thai; 2007 Jan; 90(1):59-64. PubMed ID: 17621734
    [Abstract] [Full Text] [Related]

  • 4. [Medical prophylaxis and treatment of steroid induced osteoporosis].
    Rødevand E, Mikkelsen K, Nordvåg BY, Haga HJ, Førre Ø, Johnsen V, Kvien TK.
    Tidsskr Nor Laegeforen; 2005 Jun 16; 125(12):1643-5. PubMed ID: 15976829
    [Abstract] [Full Text] [Related]

  • 5. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
    Buckley LM, Marquez M, Hudson JO, Downs RW, Vacek P, Small RE, Poses R.
    J Rheumatol; 1998 Nov 16; 25(11):2195-202. PubMed ID: 9818664
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
    Gera C, Vij AS.
    Int J Rheum Dis; 2009 Sep 16; 12(3):230-3. PubMed ID: 20374351
    [Abstract] [Full Text] [Related]

  • 7. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
    Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG.
    Arch Intern Med; 2007 Mar 26; 167(6):591-6. PubMed ID: 17389291
    [Abstract] [Full Text] [Related]

  • 8. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.
    Arthritis Rheum; 2002 Dec 26; 46(12):3136-42. PubMed ID: 12483716
    [Abstract] [Full Text] [Related]

  • 9. [Utilization of calcium, vitamin D and diphosphonates used in the treatment of osteoporosis in Denmark 1994-1996. An epidemiological analysis of nationwide prescription data].
    Juul KV.
    Ugeskr Laeger; 1998 May 25; 160(22):3207-11. PubMed ID: 9621798
    [Abstract] [Full Text] [Related]

  • 10. Doctors' beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention.
    Duyvendak M, Naunton M, van Roon EN, Brouwers JR.
    J Clin Pharm Ther; 2011 Jun 25; 36(3):356-66. PubMed ID: 21545615
    [Abstract] [Full Text] [Related]

  • 11. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort.
    Mudano A, Allison J, Hill J, Rothermel T, Saag K.
    J Rheumatol; 2001 Jun 25; 28(6):1298-305. PubMed ID: 11409123
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM, Valeriano J, Vasey FB, Carter JD.
    J Clin Rheumatol; 2006 Oct 25; 12(5):221-5. PubMed ID: 17023807
    [Abstract] [Full Text] [Related]

  • 13. [Management of glucocorticoid-induced osteoporosis].
    Soen S.
    Clin Calcium; 2005 Apr 25; 15(4):616-24. PubMed ID: 15802774
    [Abstract] [Full Text] [Related]

  • 14. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blalock SJ, Norton LL, Patel RA, Dooley MA.
    Arthritis Rheum; 2005 Oct 15; 53(5):732-9. PubMed ID: 16208664
    [Abstract] [Full Text] [Related]

  • 15. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
    van Staa TP, Leufkens HG, Cooper C.
    Osteoporos Int; 2002 Oct 15; 13(10):777-87. PubMed ID: 12378366
    [Abstract] [Full Text] [Related]

  • 16. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.
    J Rheumatol; 2009 Aug 15; 36(8):1705-14. PubMed ID: 19487264
    [Abstract] [Full Text] [Related]

  • 17. How to prevent steroid induced osteoporosis.
    Sambrook PN.
    Ann Rheum Dis; 2005 Feb 15; 64(2):176-8. PubMed ID: 15647424
    [Abstract] [Full Text] [Related]

  • 18. An evaluation of educational outreach to improve evidence-based prescribing in Medicaid: a cautionary tale.
    Zillich AJ, Ackermann RT, Stump TE, Ambuehl RJ, Downs SM, Holmes AM, Katz B, Inui TS.
    J Eval Clin Pract; 2008 Oct 15; 14(5):854-60. PubMed ID: 19018918
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT, Yosipovitch G.
    Arch Dermatol; 2006 Jan 15; 142(1):82-90. PubMed ID: 16415391
    [Abstract] [Full Text] [Related]

  • 20. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ, Clarke K.
    J Clin Rheumatol; 2009 Mar 15; 15(2):61-4. PubMed ID: 19265346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.